✦ LIBER ✦

11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?

✍ Scribed by Anagnostis, Panagiotis; Katsiki, Niki; Adamidou, Fotini; Athyros, Vasilios G.; Karagiannis, Asterios; Kita, Marina; Mikhailidis, Dimitri P.

Book ID: 121663204
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 380 KB
Volume: 62
Category: Article
ISSN: 1532-8600
DOI: 10.1016/j.metabol.2012.05.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanisms of Disease: selective inhibit

Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome

✍ Tomlinson, Jeremy W; Stewart, Paul M 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 241 KB

11β-Hydroxysteroid dehydrogenase type 1:

11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus

✍ C. D. Pereira; I. Azevedo; R. Monteiro; M. J. Martins 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

Discovery of 4-Heteroarylbicyclo[2.2.2]o

Discovery of 4-Heteroarylbicyclo[2.2.2]octyltriazoles as Potent and Selective Inhibitors of 11β-HSD1: Novel Therapeutic Agents for the Treatment of Metabolic Syndrome.

✍ Xin Gu; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 15 KB

Design, Synthesis, and Biological Evalua

Design, Synthesis, and Biological Evaluation of (Hydroxyphenyl)naphthalene and -quinoline Derivatives: Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) for the Treatment of Estrogen-Dependent Diseases

✍ Frotscher, Martin; Ziegler, Erika; Marchais-Oberwinkler, Sandrine; Kruchten, Pat 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 816 KB